V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218093 | 20083145 | 1.52 | 67.5 | Curative (C) | null | 2019-10-22 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 101159472 |
| 20218094 | 20083146 | 1.78 | 91.8 | Palliative (P) | 2017-09-27 | 2017-09-27 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101574937 |
| 20218096 | 20083147 | 1.8 | 69.2 | Palliative (P) | 2016-08-17 | 2016-08-20 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100474011 |
| 20218099 | 20083148 | 1.55 | 84.15 | null | 2018-11-03 | 2018-11-18 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + IRINOTECAN | 100603716 |
| 20218101 | 20083149 | null | null | null | null | 2016-06-17 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101040669 |
| 20218103 | 20083150 | null | null | null | 2019-08-13 | 2019-08-13 | LENVATINIB | 02 | null | LENVATINIB | 101272955 |
| 20218104 | 20083151 | null | null | null | 2016-08-02 | 2016-08-25 | HCX | N | null | HCX | 100828569 |
| 20218108 | 20083153 | 1.8 | 70.4 | null | 2018-11-08 | 2018-11-29 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | N | null | CAPECITABINE + IRINOTECAN | 101747305 |
| 20218111 | 20083156 | null | null | null | null | 2016-10-23 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100856685 |
| 20218112 | 20083157 | 1.73 | 87.7 | Curative (C) | null | 2019-10-19 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 101572820 |
| 20218113 | 20083158 | 1.63 | 74 | Palliative (P) | 2016-03-31 | 2016-04-11 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 100109417 |
| 20218115 | 20083159 | null | null | null | null | 2018-05-14 | null | null | null | LENVATINIB | 100221793 |
| 20218118 | 20083161 | 1.84 | 58.3 | null | null | 2018-12-26 | Cape+Cisplatin+Trastuzumab Load | N | Y | HCX | 100266890 |
| 20218123 | 20083162 | null | null | null | null | 2018-01-14 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100937178 |
| 20218133 | 20083164 | 1.86 | 78.8 | Palliative (P) | null | 2017-11-02 | null | null | N | LENVATINIB | 101341083 |
| 20218135 | 20083165 | 1.74 | 51.7 | Palliative (P) | 2018-12-06 | 2019-01-13 | CAPECITABINE + MITOMYCIN + RT | N | null | CAPECITABINE + MITOMYCIN + RT | 101113638 |
| 20218154 | 20083170 | 1.71 | 88.3 | Curative (C) | 2016-12-02 | 2016-12-07 | ECarboX | null | Y | CAPECITABINE + MITOMYCIN + RT | 100750336 |
| 20218161 | 20083171 | 1.64 | 73 | Palliative (P) | null | 2019-09-21 | null | null | Y | HCX | 100382991 |
| 20218164 | 20083172 | 1.62 | 70.8 | Adjuvant (A) | null | 2018-08-04 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100218812 |
| 20218165 | 20083173 | null | null | null | null | 2019-05-12 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101353144 |
| 20218174 | 20083175 | null | null | null | null | 2017-05-19 | Capecitabine (14 day) + Irinotecan | 99 | null | CAPECITABINE + IRINOTECAN | 101757664 |
| 20218175 | 20083176 | null | null | null | null | 2016-05-30 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100011708 |
| 20218177 | 20083177 | 1.74 | 65.9 | Palliative (P) | 2017-05-26 | 2017-06-03 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100857065 |
| 20218184 | 20083180 | null | null | null | 2017-04-15 | 2017-05-01 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101435094 |
| 20218188 | 20083181 | 1.84 | 68 | Palliative (P) | 2019-12-24 | 2019-12-24 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101015626 |
| 20218190 | 20083182 | 1.79 | 101 | Palliative (P) | 2016-07-18 | 2016-07-22 | CAPECITABINE + CISPLATIN + Trastuzumab | N | null | HCX | 101020629 |
| 20218193 | 20083183 | 1.59 | 75 | Neo-adjuvant (N) | 2019-10-26 | 2019-10-29 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 100917691 |
| 20218195 | 20083185 | null | 71 | Palliative (P) | null | 2016-09-26 | null | null | N | LENVATINIB | 101728248 |
| 20218199 | 20083186 | 1.74 | null | Adjuvant (A) | 2019-09-30 | 2019-10-04 | ECarboX | N | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101100942 |
| 20218200 | 20083187 | 1.62 | 87.6 | Curative (C) | null | 2017-09-15 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100810291 |
| 20218203 | 20083188 | 1.72 | 104.4 | Curative (C) | 2017-11-28 | 2017-12-13 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101364166 |
| 20218206 | 20083190 | 1.97 | 53.6 | Palliative (P) | 2016-06-23 | 2016-06-28 | Cape+Cisplatin+Trastuzumab Load | N | N | HCX | 101701420 |
| 20218215 | 20083191 | null | null | null | 2019-09-07 | 2019-09-12 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100808239 |
| 20218216 | 20083192 | 1.7 | 96.8 | Neo-adjuvant (N) | 2017-08-08 | 2017-08-24 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | CETUXIMAB + IRINOTECAN + MDG | 100411091 |
| 20218223 | 20083193 | 1.82 | 57.8 | Palliative (P) | null | 2017-09-20 | null | null | N | CISPLATIN + ETOPOSIDE | 101529218 |
| 20218228 | 20083194 | 1.67 | 68.6 | Palliative (P) | null | 2019-11-26 | null | null | N | HCX | 101230920 |
| 20218233 | 20083195 | null | null | null | 2017-05-02 | 2017-05-27 | null | null | null | CAPECITABINE + IRINOTECAN | 101599202 |
| 20218234 | 20083196 | 1.77 | 105 | Palliative (P) | 2019-04-05 | 2019-04-07 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100366719 |
| 20218237 | 20083197 | null | null | null | 2017-04-25 | 2017-04-30 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100912160 |
| 20218240 | 20083199 | 1.55 | 63.5 | Curative (C) | 2018-10-20 | 2018-10-25 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101287669 |
| 20218249 | 20083201 | 1.74 | 137 | Palliative (P) | 2019-04-17 | 2019-04-17 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100875813 |
| 20218250 | 20083202 | null | null | null | null | 2019-09-01 | CAPECITABINE + IRINOTECAN | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101068818 |
| 20218252 | 20083203 | null | null | null | 2018-05-21 | 2018-05-25 | Capecitabine (14 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101764832 |
| 20218257 | 20083204 | null | null | null | 2018-12-25 | 2018-12-27 | null | null | null | LENVATINIB | 101095587 |
| 20218271 | 20083206 | 1.89 | 79.8 | Palliative (P) | 2020-01-29 | 2020-01-29 | LENVATINIB | 02 | N | LENVATINIB | 100348760 |
| 20218273 | 20083207 | 1.69 | 59.4 | Palliative (P) | null | 2020-01-26 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101170746 |
| 20218276 | 20083208 | 1.69 | 64 | Palliative (P) | 2016-10-01 | 2016-10-11 | null | null | N | HCX | 101284561 |
| 20218284 | 20083210 | 1.54 | 66.45 | Palliative (P) | null | 2017-07-29 | null | null | N | CAPECITABINE + IRINOTECAN | 101028868 |
| 20218285 | 20083211 | 1.7 | 67 | Neo-adjuvant (N) | null | 2018-09-05 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101136723 |
| 20218288 | 20083212 | 1.64 | null | Palliative (P) | 2019-10-02 | 2019-10-13 | null | null | N | CAPECITABINE + IRINOTECAN | 101161191 |